Skip to main content
spacbrain
The briefTuesday, 11 August 2026Updated 23:59 GMT

What changed on 11 August 2026

Also on the diary

13 dated events this weekWhat to do about them
  • FTII Redemption deadline Tue 11 Aug · broker cutoff Fri 7 Aug
  • IOAC Extension vote Tue 11 Aug · broker cutoff Fri 7 Aug
  • IPEX Extension vote Tue 11 Aug · broker cutoff Fri 7 Aug
  • SBXD Extension vote Tue 11 Aug · broker cutoff Fri 7 Aug
  • IGTA Extension vote Wed 12 Aug · broker cutoff Mon 10 Aug
  • FTII Extension vote Thu 13 Aug · broker cutoff Tue 11 Aug

… and 7 more on the calendar.

Deals


IB Acquisition to merge with GNQ Insilico, Inc. in a $500M deal

IB Acquisition agreed to merge with GNQ Insilico, Inc., a Health Care company, at a headline value of $500M.

The agreement was announced on Monday 16 March, and we hold no shareholder vote date for it yet.

A $10M PIPE is recorded alongside the deal, though no filing we hold states it, and the combined company is to trade as GNQ.

IBAC dossier The deal 0001493152-26-034626opens on sec.gov in a new tab0001493152-26-010262opens on sec.gov in a new tab0001493152-26-010261opens on sec.gov in a new tab

Inflection Point V shareholders approve the GOWell Technology Limited merger

Inflection Point V won shareholder approval for its merger with GOWell Technology Limited, an Energy company, at a headline value of $300M.

The agreement was announced on Monday 13 October, and shareholders voted on Thursday 3 September.

The companies expect to close in Q3 2026.

A $20M PIPE is recorded alongside the deal, though no filing we hold states it.

IPEX dossier The deal 0001213900-26-087896opens on sec.gov in a new tab0001213900-25-098424opens on sec.gov in a new tab

Archimedes Tech II to merge with Forge Nano, Inc. in a $1.2B deal

Archimedes Tech II agreed to merge with Forge Nano, Inc., an Information Technology company, at a headline value of $1.2B.

The agreement was announced on Monday 20 April, and we hold no shareholder vote date for it yet.

A $100M PIPE is recorded alongside the deal, though no filing we hold states it, and the combined company is to trade as FRGE.

ATII dossier The deal 0001437749-26-012856opens on sec.gov in a new tab0001437749-26-017077opens on sec.gov in a new tab

Apex Treasury to merge with TECfusions, Inc. in a $4B deal

Apex Treasury agreed to merge with TECfusions, Inc., an Information Technology company, at a headline value of $4B.

The agreement was announced on Wednesday 22 July, and we hold no shareholder vote date for it yet.

The companies expect to close in Q4 2026.

A $35M PIPE is committed alongside the deal, and the combined company is to trade as TECF.

Cash in the trust account
$350.0m$353.1m
Cash behind each share
$10.16$10.25
Shares that can still be handed back
34,470,00034,470,000

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the 10-Q of Tuesday 12 May. Cash behind each share is those two figures divided.

APXT dossier The deal 0001213900-26-080199opens on sec.gov in a new tab0001213900-26-087813opens on sec.gov in a new tab

8 more not shown (20 in this window).

In the filings


10-Q filed 2026-08-11 — trust $206.9M→$208.7M (+0.9%) · deadline 2029-02-25→2028-02-27

vs prior 10-Q 2026-05-14: trust $206.9M→$208.7M (+0.9%).

deadline 2029-02-25→2028-02-27.

Why it matters: Trust value per share is $10.12, above the $10.00 redemption floor, providing a slight premium for public shareholders. The $6.19M advisory fee will be due upon any business combination, reducing net proceeds available for the deal. Sponsor holds 5.158M Class B shares (20% of post-deal equity, subject to adjustment), aligning incentives.….

Cash in the trust account
$206.9m$208.7m
The company's own deadline
2029-02-252028-02-27

Both columns are filed figures, compared against the 10-Q of Thursday 14 May. Cash behind each share is those two figures divided.

TRGS dossier 0001213900-26-087876opens on sec.gov in a new tab

10-Q filed 2026-08-11 — the auditors raised going-concern doubt · trust $120.2M→$121.2M (+0.9%)

vs prior 10-Q 2026-05-14: going-concern doubt APPEARED.

trust $120.2M→$121.2M (+0.9%).

Why it matters: This is the first SEC filing to disclose a definitive business combination agreement, providing the target (Blackstar Orbital) and confirming the SPAC will proceed to a shareholder vote. It also provides the exact trust value per share (~$10.10), current cash burn, and sponsor's forfeiture of over-allotment shares, all critical for redem….

Cash in the trust account
$120.2m$121.2m
Cash behind each share
$10.01$10.10
Shares that can still be handed back
12,000,00012,000,000

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the 10-Q of Thursday 14 May. Cash behind each share is those two figures divided.

PONO dossier 0001213900-26-087845opens on sec.gov in a new tab

DEF 14A filed 2026-08-11 — the auditors raised going-concern doubt

vs prior DEF 14A 2026-06-08: going-concern doubt APPEARED.

Why it matters: The issuance proposal is required because the Dr. Frucht consideration, the line of credit and the revenue bonus can together exceed the NYSE American thresholds — approving it authorises dilution whose size depends on facts not fixed at the vote. The split authority runs for a year and covers multiple splits totalling up to 1-for-20, an….

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the DEF 14A of Monday 8 June. Cash behind each share is those two figures divided.

PHGE dossier 0001213900-26-087834opens on sec.gov in a new tab

10-Q filed 2026-08-11 — the auditors raised going-concern doubt · trust $350.0M→$353.1M (+0.9%)

vs prior 10-Q 2026-05-12: going-concern doubt APPEARED.

trust $350.0M→$353.1M (+0.9%).

Why it matters: Investors tracking de-SPAC timelines should note the $4.0 billion TECfusions merger establishes a concrete path to close before the standard 24-month horizon. Trust liquidity remains preserved at $353,145,504, anchoring current redemption expectations near $10.25 per share. Acknowledged going concern doubts and minimal outside cash ($568….

Cash in the trust account
$350.0m$353.1m
Cash behind each share
$10.16$10.25
Shares that can still be handed back
34,470,00034,470,000

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the 10-Q of Tuesday 12 May. Cash behind each share is those two figures divided.

APXT dossier 0001213900-26-087813opens on sec.gov in a new tab

DEF 14A filed 2026-08-11 — the auditors raised going-concern doubt

vs prior DEF 14A 2026-03-06: going-concern doubt APPEARED.

Why it matters: The post-merger company has only 786,716 shares outstanding and is seeking authorization for aggressive reverse splits and large share issuances, signaling severe dilution and capital-structure risk. The sale of CPL to the CEO's own firm for $7M in equity raises significant related-party concerns and effectively transfers litigation liab….

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the DEF 14A of Friday 6 March. Cash behind each share is those two figures divided.

MURF dossier 0001493152-26-036998opens on sec.gov in a new tab

10-Q filed 2026-08-11 — the auditors raised going-concern doubt · trust $259.9M→$262.2M (+0.9%)

vs prior 10-Q 2026-05-08: going-concern doubt APPEARED.

trust $259.9M→$262.2M (+0.9%).

Why it matters: Trust value growth provides small buffer for redemptions; cash burn rate may require additional financing; no deal progress indicates continued search; going concern warning highlights risk of liquidation if no deal by July 2027.

Cash in the trust account
$259.9m$262.2m
Cash behind each share
$10.27$10.36
Shares that can still be handed back
25,300,00025,300,000

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the 10-Q of Friday 8 May. Cash behind each share is those two figures divided.

CCII dossier 0001213900-26-087419opens on sec.gov in a new tab

10-Q filed 2026-08-11 — trust $302.5M→$305.2M (+0.9%) · deadline 2028-02-04→2026-11-06

vs prior 10-Q 2026-05-14: trust $302.5M→$305.2M (+0.9%).

deadline 2028-02-04→2026-11-06.

Why it matters: The SPAC's deadline is November 6, 2026, and its ability to complete a business combination by then is critical. Low cash outside trust and going concern doubt highlight the urgency. The trust value increase offsets some dilution but the company still lacks a target. The sponsor fee suspension signals cash preservation. Redemption mechan….

Cash in the trust account
$302.5m$305.2m
Cash behind each share
$10.52$10.62
Shares that can still be handed back
28,750,00028,750,000
The company's own deadline
2028-02-042026-11-06

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

The auditor’s going-concern sentence appeared in this filing and was not in the last one. A SPAC has to say it may not survive twelve months once its own deadline falls inside the auditor’s horizon — it is about the calendar, not the bank account, and the cash above is still there.

Both columns are filed figures, compared against the 10-Q of Thursday 14 May. Cash behind each share is those two figures divided.

KFII dossier 0001213900-26-087772opens on sec.gov in a new tab

10-Q filed 2026-08-11 — trust $172.8M→$174.4M (+0.9%) · mandate/sector language changed

vs prior 10-Q 2026-05-14: trust $172.8M→$174.4M (+0.9%).

mandate/sector language changed.

Why it matters: This filing provides the first post-IPO financial snapshot. Investors can assess the trust value per share ($10.11), the burn rate (general and administrative expenses of ~$370k for six months), and the absence of any deal progress. The filing confirms the company is still searching and has not yet signed a definitive agreement. The trus….

Cash in the trust account
$172.8m$174.4m
Cash behind each share
$10.02$10.11
Shares that can still be handed back
17,250,00017,250,000
The company's own deadline
2028-03-122028-03-12

The pot grew, and so did each share's claim on it — interest, with nobody leaving.

Both columns are filed figures, compared against the 10-Q of Thursday 14 May. Cash behind each share is those two figures divided.

SUMA dossier 0001213900-26-087886opens on sec.gov in a new tab

8-K filed 2026-08-11 — Tango Therapeutics, Inc. (Nasdaq: TNGX) reported under Item 8.01 that it has expanded its at-the-market equity program under the November 21, 2025 sa…

Why it matters: The at-the-market capacity rises from about $35.6 million remaining to $400 million in total, roughly a fourfold increase on the original programme — dilution capacity the company can draw on at its sole discretion without a further shareholder vote. The $64.4 million already sold is disclosed on the record.

BCTG dossier 0001193125-26-344997opens on sec.gov in a new tab

10-Q filed 2026-08-11 — The 10-Q filed under Commission file number 001-39417 is that of Evolv Technologies Holdings, Inc. (Nasdaq: EVLV) for the quarter ended June 30, 2026…

Why it matters: Receivables grew $8.7 million while marketable securities fell $9.9 million over six months, so cash rose without the asset base growing. Property and equipment of $129.0 million is the largest single asset, consistent with the subscription model in which the company owns deployed units. The liabilities and results are not in the portion….

EVLV dossier 0001805385-26-000049opens on sec.gov in a new tab

8-K filed 2026-08-11 — BiomX Inc. (NYSE American: PHGE) filed as Exhibit 10.1 a Share Purchase and Option Agreement dated August 5, 2026 with Mayers Ventures LLC. BiomX wil…

Why it matters: A phage-therapy company is buying an initial 10% of an Israeli drone-testing business for $50,000 and 1.3 million of its own shares, with a two-year option over control priced off financial statements that will not exist until 2028. The agreement itself states that the target's technology ownership, its customers and an existing bank lie….

PHGE dossier 0001213900-26-087839opens on sec.gov in a new tab

425 filed 2026-08-11 — Trump Media & Technology Group Corp. filed as a 425 the transcript of its August 10, 2026 second quarter earnings call, described as the company's in…

Why it matters: Two announced transactions moved in opposite directions on the same call: the TAE merger is still pre-S-4, with the draft registration statement named as the next visible milestone and no committed date, while the Crypto.com/Yorkville combination and its digital asset treasury structure are terminated by mutual agreement. The end-of-2026….

DWAC dossier 0001437749-26-027049opens on sec.gov in a new tab

49 more not shown (61 in this window).

Redemptions


Nothing to report. No new SEC-sourced redemption results were captured in this window.

New coverage


Nothing to report. No SPACs were added and no decks were extracted in this window.

From the wire

Company wires and the financial press, in this window. Headlines belong to the outlets that wrote them and open on their sites.


The full news feed

How this brief is made


  • Composed deterministically from stored primary-sourced rows — no LLM, no live fetching of facts, $0 per run.
  • Trust NAV accreted at the 3-mo T-bill par yield 4.00% (treasury.gov, 2026-09-10); accreted values are ESTIMATES and labeled as such.
  • Broker action dates count ~2 real NYSE trading days before the deadline (weekends and market holidays excluded) — still verify with your broker, whose cutoff may be earlier.
  • 520 filings were scanned for this window.
  • Items tagged "coverage" are database-ingestion events (a row was captured), not market events — the underlying facts may predate the window.
  • Dated events are summarised on this page and never turned into an instruction. An outside date is the contractual long-stop: it pays nothing, and the trust comes back only if no combination closes. Where the record holds no dated redemption event either way, the page says so instead of assuming one.

Every figure on this page is taken from a filing with the U.S. Securities and Exchange Commission and links to it. Estimates are labelled as estimates. Prices are last trades, not quotes. This is information, not investment advice.

This is a dated edition — the record of one day, kept at its own address. Editions are retained for 60 days.

Today’s brief